CASMED Names Kimberly Strusky Executive Vice President of U.S. Sales
October 05 2015 - 8:30AM
CAS Medical Systems, Inc. (NASDAQ:CASM) (CASMED),
a leader in medical devices for non-invasive patient monitoring,
announces it has named Kimberly K. Strusky as Executive Vice
President of U.S. Sales. Ms. Strusky brings to CASMED more than 25
years of sales experience in the medical device industry.
"We are pleased to welcome Kim to CASMED to lead our efforts in
accelerating the commercial success of FORE-SIGHT cerebral
oximeters and sensors in the U.S.," said Thomas M. Patton,
President and Chief Executive Officer of CASMED. "Kim is an
experienced sales professional and has built and managed sales
organizations and clinical sales teams that captured market
leadership positions. Most relevant, Kim propelled
depth-of-anesthesia monitor and disposables sales at Aspect Medical
from $10 million to $70 million annually before the company was
acquired by Covidien. Her extensive experience in conceptual and
clinical selling, sales management, strategic planning and sales
training makes Kim an important addition to the CASMED team as we
continue to build on the strong U.S. performance of our FORE-SIGHT
business, which has reported 21 consecutive quarters of
double-digit sensor sales growth."
Most recently, Ms. Strusky was Vice President of Sales at CSA
Medical, a start-up medical device company where she created and
led a sales organization selling cryoablation technologies. Earlier
in her career, she spent eight years with Baxter Healthcare and
eight years with STERIS Corporation in the field sales
organizations. Ms. Strusky received her Bachelor of Science in
Management degree from Purdue University.
About CASMED® – Monitoring What's
Vital
CASMED is a leading developer and manufacturer of medical
devices for non-invasive patient monitoring. The Company's
FORE-SIGHT Absolute Cerebral Oximeter provides a highly accurate,
non-invasive, continuous measurement of absolute cerebral tissue
oxygen saturation. Direct monitoring of tissue oxygenation
provides a superior and powerful tool to alert clinicians to
otherwise unrecognized and dangerously low levels of oxygenation of
the brain and other tissues, thereby allowing them to intervene
appropriately in the care of their patients. In addition to
FORE-SIGHT Oximeters and accessories, the Company provides a line
of bedside patient vital signs monitoring products, proprietary
non-invasive blood pressure monitoring solutions for OEM use,
neonatal intensive care supplies, and service. CASMED products are
designed to provide unique monitoring solutions that are vital to
patient care. For further information regarding CASMED, visit the
Company's website at www.casmed.com.
Company Contact CAS Medical Systems, Inc.
Jeffery A. Baird Chief Financial Officer (203) 315-6303
ir@casmed.com
Investors LHA Bruce Voss / Jody Cain (310)
691-7100 bvoss@lhai.com / jcain@lhai.com @LHA_IR_PR
Cas Medical Systems, Inc. (NASDAQ:CASM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cas Medical Systems, Inc. (NASDAQ:CASM)
Historical Stock Chart
From Sep 2023 to Sep 2024